Michael E. Pierce

1.5k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Michael E. Pierce is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Michael E. Pierce has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 11 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Michael E. Pierce's work include Asymmetric Synthesis and Catalysis (7 papers), HIV/AIDS drug development and treatment (6 papers) and Chemical Synthesis and Analysis (4 papers). Michael E. Pierce is often cited by papers focused on Asymmetric Synthesis and Catalysis (7 papers), HIV/AIDS drug development and treatment (6 papers) and Chemical Synthesis and Analysis (4 papers). Michael E. Pierce collaborates with scholars based in United States. Michael E. Pierce's co-authors include John V. Duncia, Joseph B. Santella, David J. Carini, Gregory J. Wells, A.L. Johnson, Paul E. Aldrich, Andrew T. Chiu, William A. Price, Joseph Fortunak and Pat N. Confalone and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and The Journal of Organic Chemistry.

In The Last Decade

Michael E. Pierce

28 papers receiving 1.0k citations

Hit Papers

Nonpeptide angiotensin II receptor antagonists: the disco... 1991 2026 2002 2014 1991 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives
    1991 369 citations David J. Carini, John V. Duncia et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Pierce United States 14 764 334 93 85 75 29 1.1k
Michael A. Stier United States 15 378 0.5× 377 1.1× 50 0.5× 21 0.2× 26 0.3× 37 719
David Askin United States 25 1.2k 1.6× 561 1.7× 86 0.9× 18 0.2× 66 0.9× 50 1.6k
Antonia Di Mola Italy 20 814 1.1× 249 0.7× 44 0.5× 12 0.1× 31 0.4× 69 1.1k
Jaroslav Roh Czechia 23 810 1.1× 488 1.5× 146 1.6× 111 1.3× 279 3.7× 61 1.5k
Dorota G. Piotrowska Poland 18 624 0.8× 288 0.9× 124 1.3× 73 0.9× 41 0.5× 87 947
André Alker Switzerland 14 364 0.5× 243 0.7× 56 0.6× 7 0.1× 74 1.0× 31 695
Lisbet Kværnø United States 16 478 0.6× 364 1.1× 63 0.7× 14 0.2× 34 0.5× 24 813
Joseph B. Santella United States 11 567 0.7× 312 0.9× 16 0.2× 92 1.1× 18 0.2× 19 901
Ioannis N. Houpis United States 21 964 1.3× 298 0.9× 45 0.5× 5 0.1× 34 0.5× 43 1.2k
Andrew C. Flick United States 21 829 1.1× 340 1.0× 19 0.2× 6 0.1× 144 1.9× 39 1.1k

Countries citing papers authored by Michael E. Pierce

Since Specialization
Citations

This map shows the geographic impact of Michael E. Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Pierce more than expected).

Fields of papers citing papers by Michael E. Pierce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Pierce. The network helps show where Michael E. Pierce may publish in the future.

Co-authorship network of co-authors of Michael E. Pierce

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Pierce. A scholar is included among the top collaborators of Michael E. Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Pierce. Michael E. Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuang, Shan-Ming, et al.. (2016). Crystal form control and particle size control of RG3487, a nicotinic α7 receptor partial agonist. International Journal of Pharmaceutics. 508(1-2). 109–122. 5 indexed citations
2.
Edwards, William, et al.. (2008). A Practical Method For Stabilizing Lithiated Halogenated Aromatic Compounds. Organic Process Research & Development. 12(6). 1293–1298. 10 indexed citations
3.
Cleary, Thomas P., et al.. (2007). Mono-nitration of aromatic compounds via their nitric acid salts. Tetrahedron Letters. 48(49). 8659–8664. 17 indexed citations
4.
Carini, David J., David D. Christ, John V. Duncia, & Michael E. Pierce. (2006). The Discovery and Development of Angiotensin II Antagonists. Kluwer Academic Publishers eBooks. 11. 29–56. 12 indexed citations
5.
Maurin, Michael B., et al.. (2002). Kinetics and Mechanism of Hydrolysis of Efavirenz. Pharmaceutical Research. 19(4). 517–521. 36 indexed citations
6.
Schinazi, Raymond F., John W. Mellors, Holly Bazmi, et al.. (2002). DPC 817: a Cytidine Nucleoside Analog with Activity against Zidovudine- and Lamivudine-Resistant Viral Variants. Antimicrobial Agents and Chemotherapy. 46(5). 1394–1401. 39 indexed citations
7.
Choudhury, Anusuya, Michael E. Pierce, & Pat N. Confalone. (2001). OXIDATIVE REMOVAL OFp-METH-OXYBENZYL-AMINO PROTECTING GROUP IN THE PRESENCE OF A PROXIMAL HYDROXY FUNCTION: A SOLUTION TO A PROCESS PROBLEM IN SUSTIVA® (EFAVIRENZ) SYNTHESIS. Synthetic Communications. 31(23). 3707–3714. 2 indexed citations
8.
9.
Wang, Zhe, et al.. (2000). A Practical Preparation of Terminal Alkynes from Aldehydes. The Journal of Organic Chemistry. 65(6). 1889–1891. 54 indexed citations
10.
11.
12.
Pierce, Michael E., Joseph Fortunak, & Qamrul Islam. (1996). A Practical Photochemical Synthesis of 6-AZA-1, 10-Phenanthroic Anhydride. Synthetic Communications. 26(19). 3645–3652. 1 indexed citations
13.
Pierce, Michael E., Qamrul Islam, Lilian Radesca, et al.. (1996). Stereoselective Synthesis of HIV-1 Protease Inhibitor, DMP 323. The Journal of Organic Chemistry. 61(2). 444–450. 51 indexed citations
14.
Pierce, Michael E., et al.. (1994). On the mechanism of the reduction of 1‐phenyl‐3‐(4‐pyridinylmethylene)‐2‐oxindole with sodium borohydride in methanol. Journal of Heterocyclic Chemistry. 31(1). 17–23. 4 indexed citations
15.
Pierce, Michael E., et al.. (1993). Purification of Nucleoside-5′-diphosphates: A New Ion-Exchange Method. Separation Science and Technology. 28(11-12). 1959–1970. 1 indexed citations
16.
Pierce, Michael E., et al.. (1993). A Large Scale Preparation of the Cognitive Enhancer Linopirdine. Synthetic Communications. 23(11). 1617–1625. 13 indexed citations
17.
Duncia, John V., Michael E. Pierce, & Joseph B. Santella. (1991). ChemInform Abstract: Three Synthetic Route to a Sterically Hindered Tetrazole. A New One‐Step Mild Conversion of an Amide into a Tetrazole.. ChemInform. 22(34). 7 indexed citations
18.
Duncia, John V., Michael E. Pierce, & Joseph B. Santella. (1991). Three synthetic routes to a sterically hindered tetrazole. A new one-step mild conversion of an amide into a tetrazole. The Journal of Organic Chemistry. 56(7). 2395–2400. 274 indexed citations
19.
20.
Carini, David J., John V. Duncia, Paul E. Aldrich, et al.. (1991). Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. Journal of Medicinal Chemistry. 34(8). 2525–2547. 369 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Stier Breakdown of academic impact, for papers by David Askin Breakdown of academic impact, for papers by Antonia Di Mola Breakdown of academic impact, for papers by Jaroslav Roh Breakdown of academic impact, for papers by Dorota G. Piotrowska Breakdown of academic impact, for papers by André Alker Breakdown of academic impact, for papers by Lisbet Kværnø Breakdown of academic impact, for papers by Joseph B. Santella Breakdown of academic impact, for papers by Ioannis N. Houpis Breakdown of academic impact, for papers by Andrew C. Flick
Rankless by CCL
2026